Accretion Nutraveda Limited has informed BSE Limited about an upcoming Board of Directors meeting scheduled for May 8, 2026. The meeting intimation was filed on May 1, 2026, in accordance with regulatory requirements under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Details

The board meeting has been convened primarily to consider and approve the company's audited financial results for the fiscal year that concluded on March 31, 2026. This represents a crucial milestone for stakeholders as it will provide comprehensive insights into the company's financial performance for FY26.

Company Information

Accretion Nutraveda Limited, formerly known as Accretion Nutraveda Private Limited, is listed on BSE Limited with scrip code 544694. The company secretary and compliance officer, Payal Kotadiya, signed the board meeting intimation digitally on May 1, 2026.

Regulatory Compliance

The intimation follows the mandatory disclosure requirements under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates listed companies to inform stock exchanges about board meetings where financial results are scheduled for consideration and approval.

The upcoming board meeting represents a standard corporate governance practice, ensuring transparency and timely disclosure of financial information to investors and regulatory authorities.

Accretion Nutraveda Limited has filed its quarterly compliance certificate with BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulation, 2018 for the quarter ended 31st March, 2026. The submission, dated 4th April, 2026, demonstrates the company's adherence to mandatory disclosure norms.

Regulatory Compliance Details

The certificate was issued by KFin Technologies Limited, serving as the company's Registrar and Share Transfer Agent (RTA). This document satisfies the requirements of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, which mandates quarterly reporting on dematerialization activities.

Share Dematerialization Status

KFin Technologies Limited confirmed that during Q4FY26, all shares of Accretion Nutraveda Limited remained in dematerialized form. The registrar specifically noted that no rematerialization requests were received during the quarter ended 31st March, 2026.

The certificate was signed by Dnyanesh Gharote, Vice President at KFin Technologies Limited, and submitted by Company Secretary and Compliance Officer Payal Kotadiya on behalf of Accretion Nutraveda Limited.

Regulatory Framework

This filing aligns with SEBI's depositories regulations that require companies to maintain transparency regarding their share dematerialization activities. The certificate has been furnished to all stock exchanges where the company's shares are listed, ensuring comprehensive regulatory compliance across trading platforms.